GenIbet
Oeiras
About GenIbet
GenIbet offers cGMP manufacturing excellence and a comprehensive service that encompasses cell line development, process and analytical development and cGMP production of recombinant proteins, DNA, Viral and Cell products. This, combined with in-house fill and finish capabilities, gives our clients the opportunity to go from bench to clinic in one facility. GenIbet leverages its activities on the extensive expertise in molecular biology, virology, microbial and cell culture of our partner and main shareholder, iBET (Instituto de Biologia Experimental e Tecnológica).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Seed (Apr 2006)
- Website: genibet.eu
- Phone: 351 21 446 9484
Industries & Categories
Biopharma, Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/genibet-3031790 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.